Thanks for the writeup! They have performed well last 6 quarters. It will be interesting to see how their GLR will develop next 4 quarters and will they improve their cross selling. Still less than 5% of their customers have multiple policies.
True that! Currently I find following of their FCF quite difficult due to their synthetic agents CAC financing program, so I’m focused on following up IFP growth, GLR TTM and cross sales (total of customers per product minus total customers).
Thanks for the writeup! They have performed well last 6 quarters. It will be interesting to see how their GLR will develop next 4 quarters and will they improve their cross selling. Still less than 5% of their customers have multiple policies.
Good point! Synthetic agents improve FCF (but not EBIT)… anyway I like the KPIs you are following, let’s keep in touch!
I agree, a fundamental edge against companies like ROOT is the possibility to cross sell on the customer base.
True that! Currently I find following of their FCF quite difficult due to their synthetic agents CAC financing program, so I’m focused on following up IFP growth, GLR TTM and cross sales (total of customers per product minus total customers).